A 15-minutes oral presentation that was given in ISQua's 32nd International Conference, Doha, October 2015 by Dr. Yasser Amer under the track: "Quality and Safety in Developing Countries"
A sample of slides used in our FMEA Training for Healthcare. This 3-day class is ideal for quality facilitators with hospitals and health systems. The key deliverable is a preliminary FMEA on a high-risk process of the client's choosing, complete with an improvement plan.
A sample of slides used in our FMEA Training for Healthcare. This 3-day class is ideal for quality facilitators with hospitals and health systems. The key deliverable is a preliminary FMEA on a high-risk process of the client's choosing, complete with an improvement plan.
We all want to support the accomplishment of safe and trouble-free products and processes. Failure Mode and Effects Analysis has the potential to be a powerful reliability tool to reduce product design and manufacturing risk in a cost effective manner. With shorter product development times, tighter budgets and intense global competition, Design for Reliability tools such as FMEA must be applied correctly. Yet in practice, FMEA does not always achieve the expected results. Why is it that some companies have outstanding success in their FMEA application and others do not? What is the difference between well done and poorly done FMEAs? What are the essential elements of an effective FMEA process? These questions and more are answered in these three new short courses on FMEA.
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Failure Mode & Effects Analysis (FMEA) is a step-by-step approach for identifying all possible failures in a design, a manufacturing or assembly process, or a product or service. The purpose of the FMEA is to take actions to eliminate or reduce failures, starting with the highest-priority ones. FMEA also documents current knowledge and actions about the risks of failures, for use in continuous improvement.
In this training presentation, you can teach your employees on the proper steps to construct an FMEA for a design or process, and then implement action plans to eliminate or reduce the risks of potential failures.
LEARNING OBJECTIVES
1. Understand what an FMEA is, why it is used, and when can it be deployed
2. Understand the definitions, scoring system and calculations used in an FMEA
3. Learn the steps to developing an FMEA and the pitfalls to avoid
CONTENTS
1. Introduction to FMEA
2. FMEA: Definitions, Scoring System & Calculations
3. FMEA Procedure
4. FMEA Example
In pharmaceutical industry any investigation is concluded with "Human error" as root cause then understanding needs to be built for the root cause analysis.
It is very easy to conclude as Human error, but difficult to justify.
These Presentation includes
1. Trend of Human error in various industries.
2. Facts and Finding on Human error
3. Definition of Human error.
4. Viewpoint "Human Error"
5. Understanding of Human error part-1 and 2.
6. Contributing factors for human error.
7. Human weaknesses.
8. Human limitations.
9. Let's Have part (Secret game zone)
10. Human error investigation
11. Human error reduction
12. Thank you note
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Bhaswat Chakraborty
This presentation describes Identification & differentiation of Protocol deviation & violation; Different methods of RCA & best suitable method for Multiregional Clinical Trial; CAPA management and CAPA application to other trial sites/CRO/SMO/ Country that is involved in same trial (Strategic Management and application of CAPA in MRCT)
We all want to support the accomplishment of safe and trouble-free products and processes. Failure Mode and Effects Analysis has the potential to be a powerful reliability tool to reduce product design and manufacturing risk in a cost effective manner. With shorter product development times, tighter budgets and intense global competition, Design for Reliability tools such as FMEA must be applied correctly. Yet in practice, FMEA does not always achieve the expected results. Why is it that some companies have outstanding success in their FMEA application and others do not? What is the difference between well done and poorly done FMEAs? What are the essential elements of an effective FMEA process? These questions and more are answered in these three new short courses on FMEA.
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Failure Mode & Effects Analysis (FMEA) is a step-by-step approach for identifying all possible failures in a design, a manufacturing or assembly process, or a product or service. The purpose of the FMEA is to take actions to eliminate or reduce failures, starting with the highest-priority ones. FMEA also documents current knowledge and actions about the risks of failures, for use in continuous improvement.
In this training presentation, you can teach your employees on the proper steps to construct an FMEA for a design or process, and then implement action plans to eliminate or reduce the risks of potential failures.
LEARNING OBJECTIVES
1. Understand what an FMEA is, why it is used, and when can it be deployed
2. Understand the definitions, scoring system and calculations used in an FMEA
3. Learn the steps to developing an FMEA and the pitfalls to avoid
CONTENTS
1. Introduction to FMEA
2. FMEA: Definitions, Scoring System & Calculations
3. FMEA Procedure
4. FMEA Example
In pharmaceutical industry any investigation is concluded with "Human error" as root cause then understanding needs to be built for the root cause analysis.
It is very easy to conclude as Human error, but difficult to justify.
These Presentation includes
1. Trend of Human error in various industries.
2. Facts and Finding on Human error
3. Definition of Human error.
4. Viewpoint "Human Error"
5. Understanding of Human error part-1 and 2.
6. Contributing factors for human error.
7. Human weaknesses.
8. Human limitations.
9. Let's Have part (Secret game zone)
10. Human error investigation
11. Human error reduction
12. Thank you note
Deviations management in the context of ICH Q9 Q10
Similar to FAILURE MODE AND EFFECT ANALYSIS (FMEA) FOR IMPLEMENTATION OF CLINICAL PRACTICE GUIDELINES AT A TERTIARY CARE TEACHING HOSPITAL IN SAUDI ARABIA
Root cause Analysis (RCA) & Corrective and Preventive action (CAPA) in MRCT d...Bhaswat Chakraborty
This presentation describes Identification & differentiation of Protocol deviation & violation; Different methods of RCA & best suitable method for Multiregional Clinical Trial; CAPA management and CAPA application to other trial sites/CRO/SMO/ Country that is involved in same trial (Strategic Management and application of CAPA in MRCT)
This presentation to a Strategy Institute emergency planning conference for universities, colleges & K-12 schools highlights the importance and value of using standards such as CSA Z1600 for evaluating and developing university, college and school emergency management plans and programs.
Part 1. An overview on implementation of CPGs
Part 2. CPGs & HTAs
Presented during the 2nd Regional Workshop for CPG Adaptation, Tunis, Tunisia May 24-26 2016
A collaborative between INA Sante, WHO-EMRO, KSU
CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.Quality Management in clinical operations are Centralized Monitoring, Study Quality Metrics and CRO Oversight.
Harmonization of Laboratory Indicators, 09 03-2017Ola Elgaddar
Most of Medical labs are having KPIs to monitor their performance and enhance process improvement. This presentation discusses in short the IFCC attempts to reach a consensus and harmonize medical labs quality indicators.
This Presentation is about why CRO/Vendor oversight should support sponsor regulatory requirements and cost containment.
Topics covered:
1.Importance of CRO/Vendor oversight in clinical trial management.
2. Identify the ways to integrate a risk-based approaches to CRO/Vendor oversight.
3. Developing a CRO/Vendor oversight plan with appropriate KPIs/metrics to be measured.
4. Use of tools and technology for accurate and timely reporting.
Aligning data life cycle with qb d risk management principle across the produ...SANDEEP DIWAKER
Dear all,
Herewith sharing the presentation on “Aligning Data Life Cycle with QbD Risk Management Principle across the product life cycle” session conducted in Biotrains event on “Data Integrity”
Aligning data life cycle with qb d risk management principle across the produ...SANDEEP DIWAKER
Dear all,
Herewith sharing the presentation on “Aligning Data Life Cycle with QbD Risk Management Principle across the product life cycle” session conducted in Biotrains event on “Data Integrity”
Risk-based Monitoring Strategies for Improved Clinical Trial PerformanceCognizant
To address draft regulatory guidance for risk-based clinical trial monitoring, sponsors should consider strategies that utilize social, mobile, analytics and cloud technologies to create responsive methodologies that satisfy both the spirit and the letter of these new guidelines.
Risk management in pharmaceutical IndustryMahesh shinde
Risk Managements in pharmaceutical industry. Includes risk management tools for evalution.
Similar to FAILURE MODE AND EFFECT ANALYSIS (FMEA) FOR IMPLEMENTATION OF CLINICAL PRACTICE GUIDELINES AT A TERTIARY CARE TEACHING HOSPITAL IN SAUDI ARABIA (20)
A parallel workshop to the first international Evidence-based medicine conference and workshop Adopting Clinical Guidelines where I participated as a guest speaker.
https://www.ssrsa.org/
An awareness session conducted for physicians of the psyhciatry department at KSUMC on Monday 25/11/2019 at King Khalid University Hospital, Riyadh, KSA
Presented as part of the Capacity Building in Policy Briefs Development Workshop conducted by Research Chair for Evidence-Based Health Care and Knowledge Translation
In collaboration with World Health Organization, Regional Office for the Eastern Mediterranean in King Saud University 2019.
The Adapted ADAPTE approach to CPG adaptation proposed by the Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University, Egypt.
An oral presentation conducted by Prof. Tarek Omar during the national initiative of the Pediatrics Department, Armed Forces College of Medicine, themed; 'Towards National Guidelines' that was launched in 2018 and started by Pediatrics CPGs
Alexandria Pediatric Center - Scientific Meeting Series 2017 - Meeting No. (7) conducted by Dr. Yasser Sami Amer
on 22nd August 2017 in Alexandria, Egypt
Clinical Practice Guidelines initiative by the Healthcare Quality Directorate of the Alexandria University Hospitals, Alexandria, Egypt. For further details please refer to http://onlinelibrary.wiley.com/doi/10.1111/jep.12479/full
CPG adaptation project for Childhood CSE.
(Dissemination and Implementation Phase)
Training session for Pediatrics resident at King Khalid University Hospital, King Saud University Medical City
Illustration on how the CPGs Adaptation Program has helped in quality improvement through compliance with national and international accreditation standards.
What is the difference between development and adaptation of clinical practice guidelines? This was presented by Dr. Yasser Amer during the 2nd Regional Workshop for CPG adaptation, Tunis, Tunisia May 24-26 2016
Link:
https://www.facebook.com/media/set/?set=a.481589005298936.1073741852.215244758600030&type=1&l=67dff997c7
ADAPTE Phase Two: ADAPTATION PHASE
Search and Screen Module
Presented by Dr. Yasser S. Amer during the 2nd Regional Workshop for CPG Adaptation in Tunis, Tunisia May 24-26, 2016
A collaborative between INA Sante, WHO-EMRO, King Saud University
A personalized training workshop for the PRM Department Staff at KSUMC at large. The specific target audience is the CPG working groups and new committee members.
The Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument evaluates the process of practice guideline development and the quality of reporting.
The original AGREE Instrument has been updated and methodologically refined. The AGREE II is now the new international tool for the assessment of practice guidelines. The AGREE II is both valid and reliable and comprises 23 items organized into the original 6 quality domains.
http://www.agreetrust.org/
This session was conducted as a part of the 6th Resident Professional Development Course titled "Evidence-Based Medicine" in 9th SEPT 2015 at College of Medicine, King Saud University
An overview on priorities in health research was a part of a course for research methodology delivered in King Saud University College of Medicine August 2015
Overview of the progress of the KSUMC Clinical Practice Guidelines Adaptation and Implementation Program in the Department of Pediatrics which is the most active department in the program
CPG Implementation is “the phase in the guideline lifecycle in which strategies, systems, and tools are created to operationalize the knowledge and recommendations set forth by the guideline developers”, or is “ the part of the guideline lifecycle in which systems are introduced to influence clinicians’ behavior toward guideline adherence”. Implementation barriers and facilitators are defined as factors that actually prevent or enhance, respectively, changes in clinical behavior.
The concept of CPG Implementability was first defined by Shiffman as a set of characteristics that can predict the ease of and/ or obstacles to CPG implementation. Implementability is an abstract concept related to several factors, including intrinsic factors that are specific to the CPG itself and under control of the CPG development group) and extrinsic factors that are often specific to the intended healthcare settings and context of implementation. Also a validated tool for appraisal of implementability of CPGs named “GuideLine Implementability Appraisal (GLIA)” was developed by Schiffman RN et al, from the Yale Center for Medical Informatics, Yale School of Medicine and School of Nursing at Yale University in USA in 2005. A second version was released including a free online platform (electronic or e-GLIA). The GLIA considers only the intrinsic factors in the appraisal and is organized into two parts; part 1, including the global dimension with seven questions that examine the entire CPG document as a whole, and part 2, including the other nine dimensions with twenty-four questions that appraise each recommendation individually regarding the identified nine intrinsic factors or dimensions of implementability. The nine dimensions are decidability, executability, effect on the process of care, presentation and formatting, measurable outcomes, apparent validity, novelty/ innovation, flexibility, and computability.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
Stem Cell Solutions: Dr. David Greene's Path to Non-Surgical Cardiac CareDr. David Greene Arizona
Explore the groundbreaking work of Dr. David Greene, a pioneer in regenerative medicine, who is revolutionizing the field of cardiology through stem cell therapy in Arizona. This ppt delves into how Dr. Greene's innovative approach is providing non-surgical, effective treatments for heart disease, using the body's own cells to repair heart damage and improve patient outcomes. Learn about the science behind stem cell therapy, its benefits over traditional cardiac surgeries, and the promising future it holds for modern medicine. Join us as we uncover how Dr. Greene's commitment to stem cell research and therapy is setting new standards in healthcare and offering new hope to cardiac patients.
Trauma Outpatient Center is a comprehensive facility dedicated to addressing mental health challenges and providing medication-assisted treatment. We offer a diverse range of services aimed at assisting individuals in overcoming addiction, mental health disorders, and related obstacles. Our team consists of seasoned professionals who are both experienced and compassionate, committed to delivering the highest standard of care to our clients. By utilizing evidence-based treatment methods, we strive to help our clients achieve their goals and lead healthier, more fulfilling lives.
Our mission is to provide a safe and supportive environment where our clients can receive the highest quality of care. We are dedicated to assisting our clients in reaching their objectives and improving their overall well-being. We prioritize our clients' needs and individualize treatment plans to ensure they receive tailored care. Our approach is rooted in evidence-based practices proven effective in treating addiction and mental health disorders.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...
FAILURE MODE AND EFFECT ANALYSIS (FMEA) FOR IMPLEMENTATION OF CLINICAL PRACTICE GUIDELINES AT A TERTIARY CARE TEACHING HOSPITAL IN SAUDI ARABIA
1. FAILURE MODE AND EFFECT ANALYSIS (FMEA)
FOR IMPLEMENTATION OF CLINICAL PRACTICE
GUIDELINES AT A TERTIARY CARE TEACHING
HOSPITAL IN SAUDI ARABIA
(ISQUA15-1434)
Amir Babiker, Yasser Amer, Hayfaa Wahabi, Khalid Alswat
Mohamed El-Faki, Sarar Mohamed, Abdulrahman Al-Nemri, Ayman Aleyadi,
Solafa Fatani, Fadi El-Jardali, Farheen Shaikh, Lubna Al-Ansary, Fahad Al-Zamil
King Saud University College of Medicine
University Medical City, Riyadh, Saudi Arabia
Quality and Safety in Developing Countries
1
2. Statement of disclosure
Dr. Yasser S. Amer
MBBCh, MPed, MHCI, CPHQ
I have no actual or potential, commercial or
academic conflict of interest to declare in relation
to this presentation/ project.
2
3. CPGs Definition
“Statements that include Recommendations intended
to optimize patient care that are informed by a
Systematic Review of evidence and an assessment of
the benefits and harms of alternative care options”
Committee on Standards for Developing Trustworthy CPG
(IOM-AHRQ 2011)
3
Introduction
4. CPG Implementation
“The concrete activities and interventions
undertaken to turn policies into desired results“
Guidelines for clinical practice: from development to use. IOM, 1992
CPGs Practice
4
7. Clinical Practice Guidelines (CPGs) Program of King Saud
University Medical City
KSUMC CPG Program Partners:-
• KSUMC-Wide CPGs Steering Committee;
• Clinical Departments (20 CPGs Depart. Committees);
• Research Chair for Evidence-Based Health Care and
Knowledge Translation (CEBHC-KT);
• Quality Management Department; DQTs
• Top Management & Leadership of KSU College of
Medicine and KSU Medical City
IMPLEMENT
QIP
ADAPT
Methods
7
8. Guidelines International Network (G-I-N)
www.g-i-n.net
EBHC-KT Chair, King Saud University: Org. Member since 2009
(1st Member from Gulf & 3rd Member from MENA Countries)
Founded in Nov.
2002
8
9. Historical background - FMEA
• 1940s – US Armed Forces Military Procedures (FMECA: Failure
mode, effects, and criticality analysis)
• 1960s –
NASA
Civil aviation industry
• 1970s – Automotive industry
• 1999 – Healthcare adaptation (HFMEA™): VA National Center
for Patient Safety, US Department of Veterans Affairs
• 2000s – Promoted in the Joint Commission PS Standards.
9
10. Definition of FMEA
“a systematic, proactive method for evaluating a
process to identify where and how it might fail and to
assess the relative impact of different failures (failure
modes), in order to identify the parts of the process
that are most in need of change” (2015)
10
11. What does FMEA include?
FMEA includes review of the following:-
• Steps in the process
• Failures modes (what could go wrong?)
• Failure causes (Why would failure happen?)
• Failure effects (What would be the consequences of each
failure?)
11
13. RESULTS
The KSUMC CPG program resulted in the adaptation
of 28 CPGs in different departments with different
progress in implementation (including 7 CPGs
finalized & 4 in progress in the department of
Pediatrics).
13
14. 5 Steps of HFMEA
STEP 1 - Define the HFMEA Topic CPG Implementation
STEP 2 - Assemble a multidisciplinary
team
Pilot in Pedia. DQT/ CGC
(phys., pharm., nurs.)
STEP 3 - Graphically describe the
process
STEP 4 - Conduct a hazard analysis Failure modes, causes,
effects and RPN Matrix &
evaluate results
STEP 4 - Actions & outcome measures Assign responsible team for
actions then monitor
afterwards for risk reduction
Re-calculate the RPN to compare/ evaluate any
change in the process (residual risk) “We are here now!”14
15. Steps: CPGs Implementation
CPG Lifecycle – The ‘living’ CPG !
1. Adaptation of Evidence-Based Clinical Practice Guidelines (EBCPGs)
2. Dissemination of 'Approved' EBCPGs
3. Implementation of 'Approved' EBCPGs
4. Measurement / Evaluation of EBCPGs (M&E)
5. Networking and linking with existing projects in KSUMC
6. Sharing the experience with similar EBCPGs programs/ Initiatives
(nationally/ internationally)15
16. • Set Up Phase: CPG topic selection, team formation, leadership support
• Adaptation phase: search/screen/select of CPGs, Evaluation (AGREE),
• Finalization Phase: External review, response to reviewers' comments, implementation sectionCPG Adaptation
•Awareness of the approved CPGs
•Available implementation tools (printed/ electronic)
•Educational/ training activities
CPG Dissemination
•Implementation tools
•implementation strategies
•HIS/ EMR/ CPOE/ Order Sets/ CDS
CPG Implementation
•Performance/ quality measures/ indicators
•Data management (collection, cleaning, analysis)
•Post-auditing actions
CPG Monitoring/ Evaluation
•Local
•National
•International
Networking with existing
projects
•Collaboration with national CPG programs & iniatives
•Collaboration with international CPG programs & iniatives
Sharing the experience with similar CPG
programs
16
18. RPN Calculation
(1 – 10)Likelihood of
Occurrence (Occ.)
(1 – 10)
Note:
1 = very likely it WILL be detected
10 = very likely it WILL NOT be detected
Likelihood of Detection
(Det.)
(1 – 10)Severity (Sev.)
(Occ × Det × Sev)Risk Priority Number
(RPN)
18
21. RESULTS – Major Failure Modes
The identified potential failure modes in CPGs
implementation with the highest RPN (≥ 80):-
1. Auditing of the CPGs (e.g. data management process).
2. Adaptation process (e.g. AGREE appraisal, Ext. review).
3. Networking with existing projects.
4. Awareness/training activities.
5. Accessible printed & electronic implementation tools
6. Advocates from clinical/ quality champions
21
22. RESULTS - Actions taken
1. Auditing: supported by Pedia. CGC, DQT & QMD as a part
of Quality sustainability plan and CPG Program.
2. Adaptation: (e.g. AGREE: 4 appraisers, Review: all
Stakeholders)
3. Networking: (e.g. Dept. QIP, CPD, Accreditation, Research)
4. Awareness/ training activities: organized regularly.
5. Printed & electronic copies*: Available and accessible to
HC providers at points of care. *eSiHi!
6. Champions: Consultants/ senior practitioners encouraged
to get involved in CPG adaptation/ implementation.22
24. Poster presentation
Quality and Safety in Developing Countries
# 1439
Clinical Documentation Success Story in Department
of Medicine, KKUH, KSUMC
“Paper-to-Electronic Challenge!”
24
25. Conclusion - Application of HFMEA …
1) Identifies potential failures and monitor
barriers in CPGs implementation.
2) identifies the most important and relevant
critical activities that need to be adopted in
order to achieve a successful outcome
3) It is vital to address these recommendations
and actions that result from the FMEA.
25